NCT01869686View on ClinicalTrials.gov

Study to Evaluate the Concentration of Denosumab in Seminal Fluid in Healthy Men After a Single Subcutaneous Dose

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Healthy Volunteer
Interventions
BIOLOGICAL

Denosumab

60 mg

Trial Locations (1)

66212

Research Site, Overland Park

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01869686 - Study to Evaluate the Concentration of Denosumab in Seminal Fluid in Healthy Men After a Single Subcutaneous Dose | Biotech Hunter | Biotech Hunter